FY2027 Earnings Forecast for WST Issued By Zacks Research

West Pharmaceutical Services, Inc. (NYSE:WST) – Zacks Research issued their FY2027 earnings estimates for West Pharmaceutical Services in a note issued to investors on Thursday, March 6th. Zacks Research analyst I. Bandyopadhyay forecasts that the medical instruments supplier will earn $8.18 per share for the year. The consensus estimate for West Pharmaceutical Services’ current full-year earnings is $6.62 per share.

West Pharmaceutical Services (NYSE:WST) last posted its quarterly earnings results on Thursday, February 13th. The medical instruments supplier reported $1.82 EPS for the quarter, topping analysts’ consensus estimates of $1.75 by $0.07. West Pharmaceutical Services had a net margin of 17.03% and a return on equity of 18.60%. The firm had revenue of $748.80 million for the quarter, compared to analysts’ expectations of $739.59 million.

Other analysts have also issued reports about the stock. StockNews.com lowered shares of West Pharmaceutical Services from a “buy” rating to a “hold” rating in a research note on Thursday, February 27th. Deutsche Bank Aktiengesellschaft raised shares of West Pharmaceutical Services from a “hold” rating to a “buy” rating and set a $250.00 price objective for the company in a research note on Friday, February 14th. Wolfe Research assumed coverage on shares of West Pharmaceutical Services in a research note on Friday, December 13th. They issued a “peer perform” rating for the company. UBS Group raised shares of West Pharmaceutical Services from a “neutral” rating to a “buy” rating and increased their price target for the company from $350.00 to $390.00 in a research report on Thursday, December 12th. Finally, KeyCorp decreased their price target on shares of West Pharmaceutical Services from $470.00 to $325.00 and set an “overweight” rating for the company in a research report on Friday, February 14th. Two analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $344.00.

West Pharmaceutical Services Stock Down 0.5 %

NYSE:WST opened at $231.55 on Friday. West Pharmaceutical Services has a 1-year low of $197.01 and a 1-year high of $400.88. The company has a 50-day moving average of $295.38 and a 200 day moving average of $305.85. The firm has a market cap of $16.74 billion, a PE ratio of 34.61, a price-to-earnings-growth ratio of 6.74 and a beta of 1.09. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.79 and a quick ratio of 2.23.

Hedge Funds Weigh In On West Pharmaceutical Services

Hedge funds and other institutional investors have recently modified their holdings of the stock. Whipplewood Advisors LLC purchased a new position in shares of West Pharmaceutical Services in the 4th quarter valued at approximately $25,000. Retirement Wealth Solutions LLC purchased a new position in shares of West Pharmaceutical Services in the 4th quarter valued at approximately $34,000. Centricity Wealth Management LLC purchased a new position in shares of West Pharmaceutical Services in the 4th quarter valued at approximately $35,000. Cornerstone Planning Group LLC raised its position in shares of West Pharmaceutical Services by 57.1% in the 4th quarter. Cornerstone Planning Group LLC now owns 110 shares of the medical instruments supplier’s stock valued at $38,000 after purchasing an additional 40 shares during the last quarter. Finally, Brooklyn Investment Group purchased a new position in shares of West Pharmaceutical Services in the 3rd quarter valued at approximately $41,000. 93.90% of the stock is owned by hedge funds and other institutional investors.

West Pharmaceutical Services Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 7th. Shareholders of record on Wednesday, April 30th will be given a dividend of $0.21 per share. This represents a $0.84 annualized dividend and a dividend yield of 0.36%. The ex-dividend date of this dividend is Wednesday, April 30th. West Pharmaceutical Services’s payout ratio is 12.56%.

West Pharmaceutical Services Company Profile

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.